Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(6/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(6/week)
News
United States
(507/week)
Manufacturing
(335/week)
Energy
(278/week)
Technology
(347/week)
Other Manufacturing
(263/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Elagolix
Sep 05, 2018
Neurocrine Biosciences to Present at the Morgan Stanley 16th Annual Global Healthcare Conference
Aug 22, 2018
AbbVie Announces Positive Topline Results from Phase 3 Extension Study Evaluating Investigational Elagolix in Women with Uterine Fibroids
Jul 31, 2018
Neurocrine Biosciences Reports Second Quarter 2018 Financial Results
Jul 24, 2018
AbbVie Receives U.S. FDA Approval of ORILISSA(TM) (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
Jul 10, 2018
Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2018 Financial Results
Jun 08, 2018
Chief Executive Officer of Neurocrine Biosciences, Kevin Gorman, Ph.D., Named EY Entrepreneur Of The Year® 2018 San Diego
May 09, 2018
Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference
Apr 27, 2018
AbbVie Presents New Investigational Data for Elagolix at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting
Apr 23, 2018
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2018 Financial Results
Apr 10, 2018
AbbVie and Neurocrine Biosciences Announce PDUFA Target Date of Q3 2018 for Elagolix in Endometriosis-Associated Pain
Mar 13, 2018
AbbVie Announces Positive Topline Results from Second Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids
Mar 07, 2018
Neurocrine Biosciences to Present at Upcoming Healthcare Conferences
Feb 21, 2018
AbbVie Announces Positive Topline Results from Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids
Feb 13, 2018
Neurocrine Biosciences Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Investor Update for 2018
Feb 08, 2018
Neurocrine Biosciences to Present at the Leerink Partners 7th Annual Global Healthcare Conference
Feb 06, 2018
Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2017 Financial Results
Jan 07, 2018
Neurocrine Biosciences Announces Retirement of Christopher O'Brien, M.D., and Appointment of Eiry W. Roberts, M.D., as Chief Medical Officer
Jan 07, 2018
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2017 Sales Results and 2018 Program Milestones
Jan 02, 2018
Neurocrine Biosciences to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 07, 2017
Neurocrine Biosciences to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference
‹‹
Page 2
››
Latest News
Apr 20, 2024
nVent Electric plc to Release First Quarter 2024 Financial Results and Host Earnings Conference Call on...
Apr 20, 2024
Activated Carbon Global Strategic Business Report 2024-2030: Led by China, Asia-Pacific Enjoys Commanding...
Apr 20, 2024
AeroMech Announces RVSM Certification Program for Piper M700 Fury
Apr 20, 2024
Divert Announces Purchase of New Site in Lexington, North Carolina for Future Integrated Diversion &...
Apr 20, 2024
Scepter Simplifies Refueling with the Flip of a Switch
Apr 20, 2024
Global Large Caliber Ammunition Market Analysis and Forecasts, 2023-2024 and 2033: Smart Ammunition...
Apr 20, 2024
Arcline Completes Acquisition of Kaman
Apr 20, 2024
L3Harris Announces Quarterly Dividend
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events